Prophylactic mastectomy - Evaluation and treatment of high risk patients

Swiss Surgery

Volumn 8, Issue 2, 2002, Pages 45-52

  Remmel, Eugenia ^a   Harder, F ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

BRCA1; BRCA2; Breast cancer; Family breast cancer; Prophylactic mastectomy; Prophylactic surgery

Indexed keywords

PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

BREAST CANCER; BREAST RECONSTRUCTION; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CHEMOPROPHYLAXIS; CONFERENCE PAPER; FEMALE; GENE MUTATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; ONCOGENE; PATIENT SELECTION; RISK ASSESSMENT; TREATMENT INDICATION;

EID: 0036229663     PISSN: 10239332     EISSN: None     Source Type: Journal    
DOI: 10.1024/1023-9332.8.2.45     Document Type: Conference Paper

References (49)

1. Breast cancer-epidemiology, risk factors, and genetics
2. The current role of prophylactic mastectomy
3. Breast cancer detection demonstration project: Five-year summary report
4. Genetic analysis of breast cancer in the cancer and steroid hormone study
5. Epidemiology of breast cancer: Findings from the Nurses' Health Study
6. Mammographic screening of the high-risk women
7. Contralateral breast carcinoma: An assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow up
8. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
9. Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients
10. Radial scars in benign breast biopsy specimens and the risk of breast cancer
11. Atypical hyperplastic lesions of the female breast a long-term follow-up study
12. Lobular carcinoma in situ of the breast
13. Autosomal dominant inheritance of early-onset breast cancer: Implication for risk prediction
14. The woman at increased risk for breast cancer: Evaluation and management strategies
15. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer
16. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
17. The breast surgeon's role in BRCA1 and BRAC2 testing
18. The calculation of breast cancer risk for woman with first degree family history of ovarian cancer
19. Toward an integrated approach to molecular epidemiology
20. Increased risk for cancer in patients with the Peutz-Jeghers syndrome
21. Management of patients at high-risk for breast cancer
22. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk
23. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer
24. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast Cancer Project P-1 Study
25. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women
26. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
27. Continued breast cancer risk reduction in postmenopausal women treated with raloxifen: 4-Year results from the MORE trial. Multiple outcomes of raloxifen evaluation
28. Decision analysis of Tamoxifen for the prevention of invasive Breast Cancer
29. Prophylactic mastectomy and inherited predisposition to breast carcinoma
30. Prophylactic surgery in women with a hereditary predisposition to breast cancer and ovarian cancer
31. Effectiveness of prophylactic mastectomy in the prevention of breast tumors in C3H mice
32. Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy
33. Glandular excision in total glandular mastectomy and modified radical mastectomy: A comparison
34. Primary breast cancer after prophylactic mastectomy (clinical conference)
35. Subcutaneous mastectomy data: Final statistical analysis
36. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
37. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations
38. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation
39. Prophylactic mastectomy
40. Skin sparing mastectomy: Anatomy and technical considerations
41. Skin-sparing mastectomies
42. Conventional TRAM flap versus free microsurgical TRAM flap for immediate breast reconstruction
43. SSO develops position statement on prophylactic mastectomies
44. A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancer
45. Issues of regret in women with contralateral prophylactic mastectomy